EARNEST Partners’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-49
| Closed | -$2.22K | – | 679 |
|
|
2023
Q3 | $2.22K | Hold |
49
| – | – | ﹤0.01% | 981 |
|
|
2023
Q2 | $2.01K | Hold |
49
| – | – | ﹤0.01% | 992 |
|
|
2023
Q1 | $1.75K | Hold |
49
| – | – | ﹤0.01% | 1005 |
|
|
2022
Q4 | $1.85K | Hold |
49
| – | – | ﹤0.01% | 1007 |
|
|
2022
Q3 | $2K | Hold |
49
| – | – | ﹤0.01% | 976 |
|
|
2022
Q2 | $2K | Hold |
49
| – | – | ﹤0.01% | 998 |
|
|
2022
Q1 | $2K | Hold |
49
| – | – | ﹤0.01% | 1023 |
|
|
2021
Q4 | $1K | Hold |
49
| – | – | ﹤0.01% | 1106 |
|
|
2021
Q3 | $2K | Hold |
49
| – | – | ﹤0.01% | 1030 |
|
|
2021
Q2 | $2K | Hold |
49
| – | – | ﹤0.01% | 1037 |
|
|
2021
Q1 | $2K | Hold |
49
| – | – | ﹤0.01% | 1033 |
|
|
2020
Q4 | $3K | Hold |
49
| – | – | ﹤0.01% | 938 |
|
|
2020
Q3 | $2K | Hold |
49
| – | – | ﹤0.01% | 961 |
|
|
2020
Q2 | $3K | Hold |
49
| – | – | ﹤0.01% | 867 |
|
|
2020
Q1 | $2K | Hold |
49
| – | – | ﹤0.01% | 890 |
|
|
2019
Q4 | $3K | Hold |
49
| – | – | ﹤0.01% | 922 |
|
|
2019
Q3 | $3K | Hold |
49
| – | – | ﹤0.01% | 892 |
|
|
2019
Q2 | $3K | Hold |
49
| – | – | ﹤0.01% | 912 |
|
|
2019
Q1 | $4K | Hold |
49
| – | – | ﹤0.01% | 823 |
|
|
2018
Q4 | $3K | Hold |
49
| – | – | ﹤0.01% | 866 |
|
|
2018
Q3 | $3K | Hold |
49
| – | – | ﹤0.01% | 929 |
|
|
2018
Q2 | $2K | Hold |
49
| – | – | ﹤0.01% | 1026 |
|
|
2018
Q1 | $2K | Hold |
49
| – | – | ﹤0.01% | 997 |
|
|
2017
Q4 | $2K | Buy |
+49
| New | +$2K | ﹤0.01% | 994 |
|
|
2017
Q1 | – | Sell |
-49
| Closed | -$2K | – | 558 |
|
|
2016
Q4 | $2K | Buy |
+49
| New | +$2K | ﹤0.01% | 925 |
|